MeSH tree: C06.130
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation ...
Mar 13, 2025
0
17
Researchers at Karolinska Institutet and Karolinska University Hospital have identified biomarkers in the blood that can be used to distinguish gallbladder cancer from inflammation of the gallbladder. This could lead to fewer ...
Mar 3, 2025
0
13
Biliary tract cancer is increasing in incidence and mortality across Europe, with more people under the age of 60 years old now impacted by the disease. However, despite this, knowledge about these tumors remains low both ...
Feb 20, 2025
0
14
In a clinical report issued by the American Academy of Pediatrics and published online Feb. 18 in Pediatrics, recommendations are presented to assist primary care providers in identifying biliary atresia in newborns by 2 ...
Feb 18, 2025
0
9
GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings. However, over the past few years, these medications have become popular due to their weight loss and ...
Feb 17, 2025
0
29
An antibiotic used to treat infective diarrhea could be an effective drug for a type of inflammatory bowel disease, a new study has found.
Feb 10, 2025
0
53
Stents to treat various blockages in the human body can themselves become blocked, but a new sensor developed at the University of Michigan for stents that are used in the bile duct may one day help doctors detect and treat ...
Oct 31, 2024
0
53
Peking University-led researchers have modified an existing treatment for liver disease that does not cause itchiness, a common side effect of existing treatments.
What influences the extent of scar tissue, or fibrosis, that develops in the liver when people suffer from liver disease? While a small amount of fibrosis is a normal part of the healing process, excessive fibrosis can occur, ...
Oct 4, 2024
0
17
The U.S. Food and Drug Administration has approved Regeneron's Dupixent (dupilumab) as an add-on maintenance treatment for adults with inadequately controlled chronic obstructive pulmonary disease (COPD) and an eosinophilic ...
Oct 2, 2024
0
47
